Product
Intrathecal Resiniferatoxin
1 clinical trial
2 indications
Indication
Intractable PainIndication
Palliative CareClinical trial
A Phase I Study of the Intrathecal Administration of Resiniferatoxin for Treating Severe Refractory Pain Associated With Advanced CancerStatus: Recruiting, Estimated PCD: 2025-02-07